147 related articles for article (PubMed ID: 728386)
1. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
Kettner C; Shaw E
Biochemistry; 1978 Oct; 17(22):4778-84. PubMed ID: 728386
[TBL] [Abstract][Full Text] [Related]
2. The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone.
Kettner C; Shaw E
Biochim Biophys Acta; 1979 Jul; 569(1):31-40. PubMed ID: 465506
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikrein.
Tsuda Y; Teno N; Okada Y; Wanaka K; Bohgaki M; Hijikata-Okunomiya A; Okamoto U; Naito T; Okamoto S
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3108-11. PubMed ID: 2534361
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.
Kettner C; Shaw E
Methods Enzymol; 1981; 80 Pt C():826-42. PubMed ID: 6210829
[No Abstract] [Full Text] [Related]
7. Affinity labelling of proteinases with tryptic specificity by peptides with C-terminal lysine chloromethyl ketone.
Coggins JR; Kray W; Shaw E
Biochem J; 1974 Mar; 137(3):579-85. PubMed ID: 4422496
[TBL] [Abstract][Full Text] [Related]
8. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of boar acrosin by peptidyl-arginyl-chloromethanes. Comparison of the reactivity of acrosin, trypsin and thrombin.
Kettner C; Springhorn S; Shaw E
Hoppe Seylers Z Physiol Chem; 1978 Sep; 359(9):1183-91. PubMed ID: 711159
[TBL] [Abstract][Full Text] [Related]
10. Highly selective synthetic inhibitors with regard to plasma-kallikrein activities.
Okamoto S; Okamoto U; Wanaka K; Hijikata-Okunomiya A; Bohgaki M; Naito T; Horie N; Okada Y
Adv Exp Med Biol; 1989; 247B():29-34. PubMed ID: 2610076
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
12. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
Scott CF; Wenzel HR; Tschesche HR; Colman RW
Blood; 1987 May; 69(5):1431-6. PubMed ID: 2436687
[TBL] [Abstract][Full Text] [Related]
14. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone.
Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K
Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, crystallization and properties of acetyl phenylalanyl lysine chloromethyl ketone: a potential inhibitor of serine proteases.
Murthy VV; Laster T
Experientia; 1980 Apr; 36(4):397-8. PubMed ID: 6991271
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of crotalase, a thrombin-like snake venom enzyme, by several peptide chloromethyl ketone derivatives.
Markland FS; Kettner C; Shaw E; Bajwa SS
Biochem Biophys Res Commun; 1981 Oct; 102(4):1302-9. PubMed ID: 6797424
[No Abstract] [Full Text] [Related]
17. Iodination of peptidyl chloromethyl ketones for protease affinity labels.
Rauber P; Wikstrom P; Shaw E
Anal Biochem; 1988 Feb; 168(2):259-64. PubMed ID: 3163239
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display.
Dennis MS; Herzka A; Lazarus RA
J Biol Chem; 1995 Oct; 270(43):25411-7. PubMed ID: 7592708
[TBL] [Abstract][Full Text] [Related]
19. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of N alpha-[3H]acetyl-L-lysine chloromethyl ketone and its use in the fluorographic detection of proteases.
Nishikata M
Anal Biochem; 1993 Oct; 214(1):222-6. PubMed ID: 8250226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
